2003
DOI: 10.1038/sj.gt.3301983
|View full text |Cite
|
Sign up to set email alerts
|

Progress and prospects: naked DNA gene transfer and therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
251
0
2

Year Published

2004
2004
2017
2017

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 380 publications
(255 citation statements)
references
References 24 publications
2
251
0
2
Order By: Relevance
“…Figure 7 insets show the corresponding fluorescent images (derived from EGFP expression) after 24 and 48 h incubation, which further verify the gene delivery performance. Considering the average size of LAu NVs (103.8 nm), the transfection of pDNA was probably due to receptor‐mediated macropinocytosis or transient membrane pores through the cytoplasm of cells in accordance with previous reports 39, 40. Even though the transfection efficiencies of the NVs were comparable with lipofectamine owing to the protection against direct exposure of pDNA to the intracellular trafficking enzymes, the efficiencies were still smaller than those from cationic polymer‐ or lipid‐based gene carriers41, 42 because of no polycationic addition compounds (+2.9 mV, zeta potential).…”
Section: Resultssupporting
confidence: 91%
“…Figure 7 insets show the corresponding fluorescent images (derived from EGFP expression) after 24 and 48 h incubation, which further verify the gene delivery performance. Considering the average size of LAu NVs (103.8 nm), the transfection of pDNA was probably due to receptor‐mediated macropinocytosis or transient membrane pores through the cytoplasm of cells in accordance with previous reports 39, 40. Even though the transfection efficiencies of the NVs were comparable with lipofectamine owing to the protection against direct exposure of pDNA to the intracellular trafficking enzymes, the efficiencies were still smaller than those from cationic polymer‐ or lipid‐based gene carriers41, 42 because of no polycationic addition compounds (+2.9 mV, zeta potential).…”
Section: Resultssupporting
confidence: 91%
“…The primary challenge in applying gene delivery to these applications is inefficient delivery, with extracellular and intracellular barriers both limiting the efficiency. In non-viral approaches, plasmid is complexed with cationic lipids or polymers to facilitate transfection in vitro and in vivo [1][2][3]. Complexation can enhance interactions between positively charged DNA complexes and the negatively charged cellular membrane, in addition to providing stability against degradation [4] and facilitating intracellular trafficking.…”
Section: Introductionmentioning
confidence: 99%
“…Although plasmid DNA provides transfection in vivo, complexing DNA with non-viral vectors, cationic lipids or polymers, can facilitate internalization and transfection in vitro and in vivo [1][2][3]. Complexation can facilitate uptake by enhancing interactions between positively charged DNA complexes and the negatively charged cellular membrane, in addition to providing stability against degradation [4].…”
Section: Introductionmentioning
confidence: 99%